Tamoxifen's effect in women with breast cancer

Comment

F Eisinger et al. Lancet. 2001.

. 2001 Apr 21;357(9264):1291-2.

doi: 10.1016/S0140-6736(00)04434-2.

No abstract available

Comment on

Variation in prophylactic surgery decisions.
Julian-Reynier C, Eisinger F, Evans G, Foulkes W, Sobol H. Julian-Reynier C, et al. Lancet. 2000 Nov 11;356(9242):1687. doi: 10.1016/S0140-6736(05)70394-9. Lancet. 2000. PMID: 11089849 No abstract available.
Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group.
Narod SA, Brunet JS, Ghadirian P, Robson M, Heimdal K, Neuhausen SL, Stoppa-Lyonnet D, Lerman C, Pasini B, de los Rios P, Weber B, Lynch H; Hereditary Breast Cancer Clinical Study Group. Narod SA, et al. Lancet. 2000 Dec 2;356(9245):1876-81. doi: 10.1016/s0140-6736(00)03258-x. Lancet. 2000. PMID: 11130383